A successful report with complete remission of two out of three B-cell chronic lymphocytic leukemia (CLL) patients using CD19-CAR T cells was reported from University of Pennsylvania in 2011[10]. The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.